Drugs / unrelated donor umbilical cord blood graft
unrelated donor umbilical cord blood graft
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00739141 | Aug 2008 → Oct 2021 | Hodgkins lymphoma, chronic myeloid leukemia, myelodysplastic syndrome, non-Hodgkin lymphoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | unrelated donor umbilical cord blood graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00739141 ↗ |
| Modality | Cell therapy | “The stem cells chosen for the transplant are from umbilical cord blood.” NCT00739141 ↗ |